C.R. Bard Receives Neutral Rating from Zacks (BCR)
C.R. Bard (NYSE:BCR)‘s stock had its “neutral” rating reiterated by Zacks in a research report issued to clients and investors on Thursday, Analyst Ratings News reports. They currently have a $143.00 target price on the stock. Zacks‘s price target suggests a potential upside of 4.97% from the company’s current price.
Zacks’ analyst wrote, “CR Bard’s adjusted earnings rose 18.6% to $1.91 per share for the 2014-first quarter and beat the Zacks Consensus Estimate by $0.05 as well as its own guidance. Revenues grew 8.0% and comfortably outpaced the mark. On the back of better results, the company retained its bottom line guidance for 2014. Potential benefit from the Gore litigation is now expected in 2014. However, we remain concerned about the stringent sales environment in the U.S. Moreover, some of Bard’s businesses are experiencing significant pricing and competitive pressures and low-single digit growth in international markets. As a result, we reiterate our Neutral recommendation on CR Bard and set a target of $143.00.”
C.R. Bard (NYSE:BCR) traded down 0.11% on Thursday, hitting $136.23. The stock had a trading volume of 837,942 shares. C.R. Bard has a 1-year low of $98.21 and a 1-year high of $150.13. The stock’s 50-day moving average is $143.6 and its 200-day moving average is $136.. The company has a market cap of $10.569 billion and a price-to-earnings ratio of 16.26.
C.R. Bard (NYSE:BCR) last released its earnings data on Tuesday, April 22nd. The company reported $1.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.06. The company had revenue of $799.30 million for the quarter, compared to the consensus estimate of $787.10 million. During the same quarter in the previous year, the company posted $1.44 earnings per share. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. Analysts expect that C.R. Bard will post $8.20 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, May 9th. Shareholders of record on Monday, April 28th will be paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.62%. The ex-dividend date is Thursday, April 24th.
BCR has been the subject of a number of other recent research reports. Analysts at Bank of America downgraded shares of C.R. Bard from a “buy” rating to a “neutral” rating in a research note on Monday, April 7th. They now have a $150.00 price target on the stock. Separately, analysts at BofA Merrill Lynch downgraded shares of C.R. Bard from a “buy” rating to a “neutral” rating in a research note on Monday, April 7th. They now have a $150.00 price target on the stock. Finally, analysts at Ned Davis Research upgraded shares of C.R. Bard from a “neutral” rating to a “buy” rating in a research note on Monday, March 10th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and seven have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $137.73.
C. R. Bard, Inc (NYSE:BCR) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.